Showing results (381-390 of 1,661) with videos related to
Sort By:
Pageof 167
Current Treatment Options in Oncology|April 2, 2025
Advances in Personalized Treatment and Prognostic Factors of Follicular LymphomaShijia Cheng, Yanyan LiuCurrent Treatment Options in Oncology|March 13, 2024
Circulating Tumor DNA (ctDNA) and Its Role in Gynecologic MalignanciesTali Pomerantz, Rebecca BrooksCurrent Treatment Options in Oncology|August 10, 2023
Current Approaches of Immune Checkpoint Therapy in Chronic Lymphocytic LeukemiaSaeid Taghiloo, Hossein Asgarian-OmranCurrent Treatment Options in Oncology|May 30, 2023
Utility of Measurable Residual Disease (MRD) Assessment in Mantle Cell LymphomaSimon Wu, Piers Blombery, David Westerman, et al.Current Treatment Options in Oncology|September 1, 2025
Immunotherapy in the Treatment of Undifferentiated Pleomorphic Sarcoma and MyxofibrosarcomaJerry T Wu, Elizabeth Nowak, Jarrell Imamura, et al.Current Treatment Options in Oncology|May 1, 2024
Post-Radiotherapy Dysphagia in Head and Neck Cancer: Current Management by Speech-Language PathologistsRoganie Govender, Nicky Gilbody, Gavriella Simson, et al.Current Treatment Options in Oncology|April 6, 2024
Photodynamic application in diagnostic procedures and treatment of non-melanoma skin cancersZhiya Yang, Dongmei Li, Dongmei ShiCurrent Treatment Options in Oncology|October 26, 2023
The Role of Liver Transplantation in the Treatment of Liver Metastases from Neuroendocrine TumorsDavide Citterio, Jorgelina Coppa, Carlo Sposito, et al.Current Treatment Options in Oncology|June 12, 2026
The Immunological Landscape of the Tumor Microenvironment: Implications for Immunotherapy of Unresectable and Metastatic Soft Tissue SarcomasSimo Zou, Ang Li, Shiqi Yang, et al.Current Treatment Options in Oncology|July 10, 2026
Current Treatment Options for Adult Grade 2 IDH-mutant Diffuse Gliomas in the Vorasidenib Era: Patient Selection, Sequencing, and Practical ManagementJianheng Wu, Nannan WangPageof 167